In general, the drugs that have seen price increases are specialty drugs that few people take. The majority of specialty drugs were already expensive and continue to increase in price, according to GoodRx.
Some of the largest price increases were for an antibiotic called Omeclamox-Pak, made by Cumberland Pharmaceuticals, which has had a price increase of 13.4 percent this year.
An ADHD treatment made by Neos Therapeutics called Adzenys XR-ODT has had a price increase of 10 percent this year.
BiDil, a heart failure drug made by Arbor Pharmaceuticals, has had a price increase of 9.7 percent this year.
The data shows that many drugmakers have not halted their price increases due to the COVID-19 pandemic.
Find the full data here.
More articles on pharmacy:
More drugmakers recall metformin products after finding they contain carcinogen
12 key trends in hospital pharmacy from the ASHP annual survey
Sandoz to supply Civica Rx with 6 injectable drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
